Infectious keratitis: an update on epidemiology, causative microorganisms, risk factors, and antimicrobial resistance
Corneal opacity is the 5th leading cause of blindness and visual impairment globally,
affecting~ 6 million of the world population. In addition, it is responsible for 1.5–2.0 million …
affecting~ 6 million of the world population. In addition, it is responsible for 1.5–2.0 million …
[HTML][HTML] Polymer-and lipid-based nanocarriers for ocular drug delivery: Current status and future perspectives
H Han, S Li, M Xu, Y Zhong, W Fan, J Xu, T Zhou… - Advanced Drug Delivery …, 2023 - Elsevier
Ocular diseases seriously affect patients' vision and life quality, with a global morbidity of
over 43 million blindness. However, efficient drug delivery to treat ocular diseases …
over 43 million blindness. However, efficient drug delivery to treat ocular diseases …
Defining dry eye from a clinical perspective
K Tsubota, SC Pflugfelder, Z Liu, C Baudouin… - International journal of …, 2020 - mdpi.com
Over the past decades, the number of patients with dry eye disease (DED) has increased
dramatically. The incidence of DED is higher in Asia than in Europe and North America …
dramatically. The incidence of DED is higher in Asia than in Europe and North America …
TFOS DEWS II definition and classification report
The goals of the TFOS DEWS II Definition and Classification Subcommittee were to create
an evidence-based definition and a contemporary classification system for dry eye disease …
an evidence-based definition and a contemporary classification system for dry eye disease …
TFOS DEWS II diagnostic methodology report
JS Wolffsohn, R Arita, R Chalmers, A Djalilian… - The ocular …, 2017 - Elsevier
The role of the Tear Film and Ocular Surface Society (TFOS) Dry Eye Workshop (DEWS) II
Diagnostic Methodology Subcommittee was 1) to identify tests used to diagnose and monitor …
Diagnostic Methodology Subcommittee was 1) to identify tests used to diagnose and monitor …
TFOS DEWS II management and therapy report
The members of the Management and Therapy Subcommittee undertook an evidence-
based review of current dry eye therapies and management options. Management options …
based review of current dry eye therapies and management options. Management options …
TFOS DEWS II tear film report
MDP Willcox, P Argüeso, GA Georgiev, JM Holopainen… - The ocular …, 2017 - Elsevier
The members of the Tear Film Subcommittee reviewed the role of the tear film in dry eye
disease (DED). The Subcommittee reviewed biophysical and biochemical aspects of tears …
disease (DED). The Subcommittee reviewed biophysical and biochemical aspects of tears …
TFOS DEWS II report executive summary
This article presents an Executive Summary of the conclusions and recommendations of the
10-chapter TFOS DEWS II report. The entire TFOS DEWS II report was published in the July …
10-chapter TFOS DEWS II report. The entire TFOS DEWS II report was published in the July …
[HTML][HTML] NOV03 for dry eye disease associated with meibomian gland dysfunction: results of the randomized phase 3 GOBI study
J Tauber, GJ Berdy, DL Wirta, S Krösser, JL Vittitow… - Ophthalmology, 2023 - Elsevier
Objective To evaluate the efficacy and safety of NOV03 (perfluorohexyloctane) ophthalmic
drop in patients with dry eye disease (DED) associated with meibomian gland dysfunction …
drop in patients with dry eye disease (DED) associated with meibomian gland dysfunction …
TFOS DEWS II pain and sensation report
Pain associated with mechanical, chemical, and thermal heat stimulation of the ocular
surface is mediated by trigeminal ganglion neurons, while cold thermoreceptors detect …
surface is mediated by trigeminal ganglion neurons, while cold thermoreceptors detect …